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To evaluate brainstem excitability in the facial and trigeminal pathways of the affected and unaffected side in HFS and PFPS and modifications induced by botulinum toxin treatment (BoNT-A).
The Blink Reflex (BR), BR Recovery Cycle (BRRC) and Masseter Inhibitory Reflex (MIR) were assessed in HFS (n = 10) and PFPS (n = 7), before and after BoNT-A. Facial palsy (FP; n = 4), used as lesional model, and healthy controls (n = 8), were also assessed.
BR and MIR were normal in all groups. In all patients BRRC analysis revealed a central hyperexcitability pattern following direct and indirect stimulation on both affected (p = 0.000007) and unaffected (p = 0.00007) sides, with highest effect at 500 ms interstimulus interval. BoNT-A injection did not affect this pattern in all patient groups.
These preliminary results may indicate a brainstem compensatory attempt in response to a facial damage which is severe and temporary in PFPS and subtler but persistent in HFS. Central effects of BoNT-A should be searched at a higher level than the brainstem. Ross syndrome (RS) is a rare disorder characterized by selective involvement of post-ganglionic skin sympathetic nerve fibres with absent cholinergic sudomotor fibres as hallmark of the disease. It is still not well defined whether autonomic dysfunction remain localized to skin fibres or it affects also cardiovascular autonomic system. To clarify this aspect, we report a cardiovascular autonomic system follow-up study in 4 patients affected by Ross syndrome.
We studied 4 patients affected by RS for a follow-up mean period of 5 years (range 1-10 years). All patients complained of anhydrosis with heat intolerance and showed areflexia and tonic pupil on neurological examination and absent cholinergic sudomotor fibres on skin biopsy. All patients underwent cardiovascular reflexes (CVR, head-up tilt test, Valsalva maneuver, deep breathing, isometric handgrip) and microneurography recording of muscle sympathetic nerve activity (MSNA) from common peroneal nerve.
CVR and MSNA resulted normal at baseline and unchanged over the follow-up in all patients although anhydrosis was usually widespread on patient's clinical re-evaluation.
Our preliminary study shows that cardiovascular autonomic system is not affected in Ross syndrome differently from skin autonomic activity dysfunction which tend to progress over time. Pulsed radiofrequency (PRF) short-lasting bursts allow pain modulation with no tissue necrosis. Neurophysiological evaluation of PRF possible effects has not been described yet. Objective of this study was to investigate the effects of PRF on sensory nerve conduction and H-reflex in patients with lumbosacral radicular pain.
We evaluated 23 patients with unilateral L5-S1 root pain who underwent PRF at the corresponding level of radicular symptoms. PRF was applied through a multifunctional electrode introduced via trans-sacral access for 240 s. at a frequency of 2 Hz, amplitude of 45 V and a tip temperature between 40 and 42°C. Neurophysiological evaluation was performed with the patient lying on a fluoroscopy table in the prone position. Sural sensory action potentials (SAP) and soleus H-reflex were bilaterally evaluated. Outcome measures included variation of sural nerve conduction and H-reflex parameters pre-, post-treatment with PRF and after 30 days from the procedure. P values <0.05 were considered statistically significant. A significant decrease in H/M ratio was observed in the affected side of patients with paresthesia either post-treatment (p = 0.007) and at one month follow-up (p = 0.04).
PRF might exert its clinical effects beyond DRG through an action on spinal inhibitory interneuronal circuitry. Facial nerve palsy is probably the most frequent and less tolerated adverse event in acoustic neuroma surgery.
Our goal was to identify preoperatory neurophysiological indicators of a sub-clinical facial deficit and to set up a relationship with the outcome.
Since January 2014 to December 2016, 193 patients (of 214) with acoustic neuroma (size 5-45 mm) have been examinated, few days before the surgery. 
